BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Montoya MC, Krysan DJ. Repurposing Estrogen Receptor Antagonists for the Treatment of Infectious Disease. mBio 2018;9:e02272-18. [PMID: 30563895 DOI: 10.1128/mBio.02272-18] [Cited by in Crossref: 21] [Cited by in F6Publishing: 16] [Article Influence: 5.3] [Reference Citation Analysis]
Number Citing Articles
1 Cham LB, Friedrich SK, Adomati T, Bhat H, Schiller M, Bergerhausen M, Hamdan T, Li F, Machlah YM, Ali M, Duhan V, Lang KS, Friebus-Kardash J, Bezgovsek J. Tamoxifen Protects from Vesicular Stomatitis Virus Infection. Pharmaceuticals (Basel) 2019;12:E142. [PMID: 31547012 DOI: 10.3390/ph12040142] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
2 Gediz Erturk A, Sahin A, Bati Ay E, Pelit E, Bagdatli E, Kulu I, Gul M, Mesci S, Eryilmaz S, Oba Ilter S, Yildirim T. A Multidisciplinary Approach to Coronavirus Disease (COVID-19). Molecules 2021;26:3526. [PMID: 34207756 DOI: 10.3390/molecules26123526] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
3 Andersen PI, Ianevski A, Lysvand H, Vitkauskiene A, Oksenych V, Bjørås M, Telling K, Lutsar I, Dumpis U, Irie Y, Tenson T, Kantele A, Kainov DE. Discovery and development of safe-in-man broad-spectrum antiviral agents. Int J Infect Dis 2020;93:268-76. [PMID: 32081774 DOI: 10.1016/j.ijid.2020.02.018] [Cited by in Crossref: 73] [Cited by in F6Publishing: 58] [Article Influence: 36.5] [Reference Citation Analysis]
4 Miró-Canturri A, Ayerbe-Algaba R, Vila-Domínguez A, Jiménez-Mejías ME, Pachón J, Smani Y. Repurposing of the Tamoxifen Metabolites to Combat Infections by Multidrug-Resistant Gram-Negative Bacilli. Antibiotics (Basel) 2021;10:336. [PMID: 33810067 DOI: 10.3390/antibiotics10030336] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
5 Al-Janabi AAHS. Repurposing of Tamoxifen Against the Oral Bacteria. Turk J Pharm Sci 2021;18:68-74. [PMID: 33634670 DOI: 10.4274/tjps.galenos.2019.23500] [Reference Citation Analysis]
6 Ragia G, Manolopoulos VG. Inhibition of SARS-CoV-2 entry through the ACE2/TMPRSS2 pathway: a promising approach for uncovering early COVID-19 drug therapies. Eur J Clin Pharmacol 2020;76:1623-30. [PMID: 32696234 DOI: 10.1007/s00228-020-02963-4] [Cited by in Crossref: 33] [Cited by in F6Publishing: 31] [Article Influence: 16.5] [Reference Citation Analysis]
7 Silwal P, Paik S, Jeon SM, Jo EK. Nuclear Receptors as Autophagy-Based Antimicrobial Therapeutics. Cells 2020;9:E1979. [PMID: 32867365 DOI: 10.3390/cells9091979] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
8 Prathapan P. A determination of pan-pathogen antimicrobials? Medicine in Drug Discovery 2022. [DOI: 10.1016/j.medidd.2022.100120] [Reference Citation Analysis]
9 Gaisina IN, Peet NP, Wong L, Schafer AM, Cheng H, Anantpadma M, Davey RA, Thatcher GRJ, Rong L. Discovery and Structural Optimization of 4-(Aminomethyl)benzamides as Potent Entry Inhibitors of Ebola and Marburg Virus Infections. J Med Chem 2020;63:7211-25. [PMID: 32490678 DOI: 10.1021/acs.jmedchem.0c00463] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
10 Danino MA, Giaccone D, El Khatib A, Dimitropoulos G, Doucet O, Gagnon A, Retchkiman M, Bou-Merhi J, Bernier C. Immediate breast reconstruction surgery with expander/direct implant and use of acellular dermal matrix: Does hormone therapy increases the risk of infection? Ann Chir Plast Esthet 2020;65:277-83. [PMID: 32493612 DOI: 10.1016/j.anplas.2020.03.001] [Reference Citation Analysis]
11 Miró-Canturri A, Vila-Domínguez A, Caretero-Ledesma M, Ayerbe-Algaba R, Pachón J, Jiménez-Mejías ME, Smani Y. Repurposing of the Tamoxifen Metabolites to Treat Methicillin-Resistant Staphylococcus epidermidis and Vancomycin-Resistant Enterococcus faecalis Infections. Microbiol Spectr 2021;9:e0040321. [PMID: 34668743 DOI: 10.1128/Spectrum.00403-21] [Reference Citation Analysis]
12 Silva DF, Reis LES, Machado MGC, Dophine DD, de Andrade VR, de Lima WG, Andrade MS, Vilela JMC, Reis AB, Pound-Lana G, Rezende SA, Mosqueira VCF. Repositioning of Tamoxifen in Surface-Modified Nanocapsules as a Promising Oral Treatment for Visceral Leishmaniasis. Pharmaceutics 2021;13:1061. [PMID: 34371752 DOI: 10.3390/pharmaceutics13071061] [Reference Citation Analysis]
13 Campesi I, Racagni G, Franconi F. Just a Reflection: Does Drug Repurposing Perpetuate Sex-Gender Bias in the Safety Profile? Pharmaceuticals (Basel) 2021;14:730. [PMID: 34451827 DOI: 10.3390/ph14080730] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
14 Breithaupt-Faloppa AC, Correia CJ, Prado CM, Stilhano RS, Ureshino RP, Moreira LFP. 17β-Estradiol, a potential ally to alleviate SARS-CoV-2 infection. Clinics (Sao Paulo) 2020;75:e1980. [PMID: 32490931 DOI: 10.6061/clinics/2020/e1980] [Cited by in Crossref: 26] [Cited by in F6Publishing: 23] [Article Influence: 13.0] [Reference Citation Analysis]
15 Peyclit L, Baron SA, Hadjadj L, Rolain J. In Vitro Screening of a 1280 FDA-Approved Drugs Library against Multidrug-Resistant and Extensively Drug-Resistant Bacteria. Antibiotics 2022;11:291. [DOI: 10.3390/antibiotics11030291] [Reference Citation Analysis]
16 Hu S, Yin F, Nie L, Wang Y, Qin J, Chen J. Estrogen and Estrogen Receptor Modulators: Potential Therapeutic Strategies for COVID-19 and Breast Cancer. Front Endocrinol 2022;13:829879. [DOI: 10.3389/fendo.2022.829879] [Reference Citation Analysis]
17 Ianevski A, Yao R, Simonsen RM, Myhre V, Ravlo E, Kaynova GD, Zusinaite E, White JM, Polyak SJ, Oksenych V, Windisch MP, Pan Q, Lastauskienė E, Vitkauskienė A, Matukevičius A, Tenson T, Bjørås M, Kainov DE. Mono- and combinational drug therapies for global viral pandemic preparedness. iScience 2022;25:104112. [DOI: 10.1016/j.isci.2022.104112] [Reference Citation Analysis]
18 Zou P, Heath A, Sewell C, Lu Y, Tran D, Seo SK. EXOGENOUS Sex Hormones and Sex Hormone Receptor Modulators in COVID-19: Rationale and Clinical Pharmacology Considerations. Clin Pharmacol Ther 2021. [PMID: 34888850 DOI: 10.1002/cpt.2508] [Reference Citation Analysis]
19 Farkas S, Szabó A, Hegyi AE, Török B, Fazekas CL, Ernszt D, Kovács T, Zelena D. Estradiol and Estrogen-like Alternative Therapies in Use: The Importance of the Selective and Non-Classical Actions. Biomedicines 2022;10:861. [DOI: 10.3390/biomedicines10040861] [Reference Citation Analysis]
20 Chakrabarti M, Joshi N, Kumari G, Singh P, Shoaib R, Munjal A, Kumar V, Behl A, Abid M, Garg S, Gupta S, Singh S. Interaction of Plasmodium falciparum apicortin with α- and β-tubulin is critical for parasite growth and survival. Sci Rep 2021;11:4688. [PMID: 33633135 DOI: 10.1038/s41598-021-83513-5] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
21 Wehbe Z, Hammoud SH, Yassine HM, Fardoun M, El-Yazbi AF, Eid AH. Molecular and Biological Mechanisms Underlying Gender Differences in COVID-19 Severity and Mortality. Front Immunol 2021;12:659339. [PMID: 34025658 DOI: 10.3389/fimmu.2021.659339] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
22 Peyclit L, Yousfi H, Rolain JM, Bittar F. Drug Repurposing in Medical Mycology: Identification of Compounds as Potential Antifungals to Overcome the Emergence of Multidrug-Resistant Fungi. Pharmaceuticals (Basel) 2021;14:488. [PMID: 34065420 DOI: 10.3390/ph14050488] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
23 Eyre NS, Kirby EN, Anfiteatro DR, Bracho G, Russo AG, White PA, Aloia AL, Beard MR. Identification of Estrogen Receptor Modulators as Inhibitors of Flavivirus Infection. Antimicrob Agents Chemother 2020;64:e00289-20. [PMID: 32482672 DOI: 10.1128/AAC.00289-20] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]
24 Allegretti M, Cesta MC, Zippoli M, Beccari A, Talarico C, Mantelli F, Bucci EM, Scorzolini L, Nicastri E. Repurposing the estrogen receptor modulator raloxifene to treat SARS-CoV-2 infection. Cell Death Differ 2021. [PMID: 34404919 DOI: 10.1038/s41418-021-00844-6] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
25 Bagheri A, Moezzi SMI, Mosaddeghi P, Nadimi Parashkouhi S, Fazel Hoseini SM, Badakhshan F, Negahdaripour M. Interferon-inducer antivirals: Potential candidates to combat COVID-19. Int Immunopharmacol 2021;91:107245. [PMID: 33348292 DOI: 10.1016/j.intimp.2020.107245] [Cited by in Crossref: 7] [Cited by in F6Publishing: 10] [Article Influence: 3.5] [Reference Citation Analysis]